Express Pharma
Home  »  Latest Updates  »  FIPB clears four FDI proposals worth Rs 384 cr including Lupin

FIPB clears four FDI proposals worth Rs 384 cr including Lupin

5

The proposal of Lupin pertained to grant of ESoPs to non-resident employees of the company amounting to Rs 331.64 crore

The Foreign Investment Promotion Board (FIPB) has cleared four FDI proposals worth Rs 384 crore including that of pharma firm Lupin.

“Based on the recommendations of FIPB in its meeting held on October 19, 2015, the government has approved four proposals of Foreign Direct Investment (FDI) amounting to Rs 384.45 crore,” a Finance Ministry statement said.

The proposal of Lupin pertained to grant of ESoPs to non-resident employees of the company amounting to Rs 331.64 crore.

BF Elbit Advanced Systems’ Rs 37.8 crore proposal for increasing foreign shareholding from 26 per cent to 49 per cent was also cleared.

Besides, proposals of Eucare Pharmaceuticals and Hanon Systems were cleared by the meeting of FIPB, which is chaired by Shaktikanta Das, Secretary, Economic Affairs.

The FIPB also rejected four proposals including that of Reliance Globalcom Ltd, Barefoot Resorts and Leisure lndia and Franklin Templeton Asset Management.

Comments are closed.